Hypoxygen

HypOxygen is a private, revenue-generating company that develops and sells specialized laboratory equipment for creating and maintaining hypoxic environments. Its core technology platform consists of the HypOxystation® brand of workstations, which offer precise, real-time control of oxygen levels (from 0.1% to 20%) and integrated CO2 monitoring for cell culture and research. The company serves the academic, pharmaceutical, and biotechnology research sectors, particularly in oncology, by providing critical tools to study hypoxia's role in cancer biology, neurodegeneration, and bacterial responses. HypOxygen operates as a specialized hardware and services provider within the scientific instrumentation market.

Precision-controlled hypoxic workstations (HypOxystation® line) and integrated research ecosystem for creating and maintaining low-oxygen environments for cell culture and analysis. Features real-time O2 control (0.1%-20% in 0.1% increments), CO2 monitoring, HEPA filtration, and connectivity with instruments like Seahorse Analyzers.

HypOxygen competes in the specialized market for hypoxic workstations against companies like Baker (Ruskinn) and Coy Laboratory Products. It differentiates through precise O2 control in 0.1% increments, a broad integrated product ecosystem, and a strong focus on researcher-driven design. Larger generalist lab equipment firms (Thermo Fisher, Eppendorf) offer basic tri-gas incubators but lack the same level of integrated, glovebox-style hypoxia control.